Brief report: Acute renal failure after losartan treatment in a patient with bilateral renal artery stenosis

Blood Pressure

Volumn 5, Issue 6, 1996, Pages 360-362

  Holm, Ellen A ^a   Randløv, Annette ^a   Strandgaard, Svend ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LOSARTAN; METOPROLOL; NIFEDIPINE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CASE REPORT; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; MALE; PRIORITY JOURNAL;

EID: 0029827387     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.3109/08037059609078075     Document Type: Article

References (19)

1. Case DB, Atlas SA, Marion RM, Laragh JH. Longterm efficacy of captopril in renovascular and essential hypertension. Am J Cardiol 1982; 49: 1440-6.
2. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. New Engl J Med 1991; 325: 293-302.
3. Weber MA. Clinical experience with the angiotensin II receptor antagonist losartan; a preliminary report. Am J Hypertens 1992; 5: 247S-251S.
4. Brunner HR, Christen Y, Munafo A, Lee RJ, Waeber B, Nussberger J. Clinical experience with angiotensin II receptor antagonists. Am J Hypertens. 1992; 5: 243S-246S.
5. Weber MA, Byyny RL, Pratt JH, Faisom EP, Snavely DB, Goldberg AI, Nelson EB. Blood pressure effects of the angiotensin II receptor blocker, losartan. Arch Intern Med 1995;155: 405-11.
6. Bender W, La France N, Walker WG. Mechanism of deterioration in renal function in patients with renovascular hypertension treated with enalapril. Hypertension 1984; 6 Suppl I: I-193-I-197.
7. Hricik DE, Browning PJ, Kopelman R, Goorno WE, Madias NE, Dzau VJ. Captopril-induced functional renal insufficiency in patients with bilateral renal artery stenosis or a solitary kidney. N Engl J Med 1983; 308: 373-6.
8. Mimran A, Brunner HR, Turini GA, Waeber B, Brunner DB. Effect of captopril on renal vascular tone in patients with essential hypertension. Clin Sci 1979; 57 Suppl 5: 421S-423S.
9. Brunner HR. ACE inhibitors in renal disease. Kidney Int 1992; 42: 463-79.
10. Blythe WB. Captopril and renal autoregulation. N Engl J Med 1983; 308: 390-1.
11. Bigazzi R, Bianchi S, Baldari G, et al. Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension. Am J Hypertens 1992; 6: 108-13.
12. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD for the Colaborative Study Group. The effect of,angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-62.
13. Mann JFE, Reisch C, Ritz E. Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function: a retrospective study. Nephron 1990; 55: S38-S42.
14. Andersen S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993-2000.
15. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacologic amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 1925-30.
16. Bovee KC, Wong PC, Timmermans PBMWM, Thoolen MJMC. Effects of the nonpeptide angiotensin II receptor antagonist DuP753 on blood pressure and renal function in spontaneusly hypertensive PH dogs. Am J Hypertens 1991; 4: 327S-333S.
17. Wong PC, Hart SD, Duncia JV, Timmermans PBMWM. Nonpeptide angiotensin II receptor antagonists: studies with DuP753 and EXP3174 in dogs. Eur J Pharmacol 1991; 202: 323-30.
18. Lafayette RA, Mayer G, Park SK, Meyer TW. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992; 90: 766-71.
19. Gansevoort RT, De Zeeuw D, De Jong PE. Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Kidney Int 1994; 45: 861-7.